HLG yields 14.00% · JNJ yields 2.13%● Live data
📍 HLG pulled ahead of the other in Year 1
Combined, HLG + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of HLG + JNJ for your $10,000?
Hailiang Education Group Inc. provides K-12 educational and management services in the People's Republic of China. The company operates 14 affiliated schools; and 27 managed schools. It offers K-12 student management, high school curriculum education, and operation and management services, including branding, academic management, education resources, school culture, admission, finance, human resources, procurement, IT, internal audit, and property and logistics management services, as well as after-school enrichment, accommodations, and transportation services. The company also provides ancillary educational services, such as well-rounded education, academic subject tutoring, study trip, and overseas study consulting services; and hotel management services. In addition, its schools offer basic educational and international programs at the primary school, middle school, and high school levels; courses designed for students, such as A-levels courses for the United Kingdom universities, AP courses for the United States universities, Victorian Certificate of Education (VCE) courses for Australian universities, and International Baccalaureate (IB) courses for various countries in the world; and language courses, including Japanese, Korean, and Spanish. As of June 30, 2021, the company had 10,402 students enrolled in its affiliated schools; and 43,897 students enrolled in its managed schools. Hailiang Education Group Inc. was founded in 1995 and is based in Hangzhou, the People's Republic of China.
Full HLG Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.